Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-17-000630)

Filing Details

Accession Number:: 0001144204-17-000630
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-01-04 17:09:10
Reporting Period:: 2017-01-04

Filing Date:: 2017-01-04
Accepted Time:: 2017-01-04 17:09:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1208261	Immune Pharmaceuticals Inc	IMNP	Pharmaceutical Preparations (2834)	521841431

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1589342	Daniel Kazado	C/O Immune Pharmaceuticals Inc. 430 East 29Th Street, Suite 940 New York NY 10016		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-01-04	76,503	$0.19	1,145,171	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Restricted shares issued for payment of accrued fees for board services issued at a conversion price equal to the closing price of the Company's common stock on the date immediately preceding the date that the Company's board of directors approved such conversion.